Evidence map›Paper›PMID 42079230›Full record

ArticlebioRxiv : the preprint server for biology2026

scVIP: personalized modeling of single-cell transcriptomes for developmental and disease phenotypes.

Hsin-Yu Lai, Yehchan Yoo, Andreas Tjärnberg, Ruoxin Li, Ziyuan He, Kyle J Travaglini, Qi Qiao, Anamika Agrawal, Omar Kana, Cindy van Velthoven and 7 more

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Hsin-Yu LaiAllen Institute, Seattle, WA, USA.ORCID 0000-0002-5783-3156
Yehchan YooUniversity of Washington, Seattle, WA, USA.
Andreas TjärnbergAllen Institute, Seattle, WA, USA.ORCID 0000-0003-0064-1791
Ruoxin LiAllen Institute, Seattle, WA, USA.
Ziyuan HeAllen Institute, Seattle, WA, USA.
Kyle J TravagliniAllen Institute, Seattle, WA, USA.ORCID 0000-0003-3164-6448
Qi QiaoUniversity of Kentucky, Lexington, KY, USA.
Anamika AgrawalAllen Institute, Seattle, WA, USA.ORCID 0000-0002-1213-2321
Omar KanaAllen Institute, Seattle, WA, USA.ORCID 0000-0002-7772-4694
Cindy van VelthovenAllen Institute, Seattle, WA, USA.ORCID 0000-0001-5120-4546
Jeff CarrollAllen Institute, Seattle, WA, USA.ORCID 0000-0003-1711-8868
Mark GillespieAllen Institute, Seattle, WA, USA.
Shubhabrata MukherjeeUniversity of Washington, Seattle, WA, USA.ORCID 0000-0003-2522-2884
David W FardoUniversity of Kentucky, Lexington, KY, USA.ORCID 0000-0002-7207-4696
Xiaojun LiAllen Institute, Seattle, WA, USA.
Ed LeinAllen Institute, Seattle, WA, USA.ORCID 0000-0001-9012-6552
Mariano Ignacio GabittoAllen Institute, Seattle, WA, USA.ORCID 0000-0001-6911-344X

Funding

Genetic Architecture of Pure Alzheimer's Disease and Mixed PathologyR01AG082730 · NIA · UNIVERSITY OF WASHINGTON · PI David William Fardo, Shubhabrata Mukherjee · 2023 to 2026
$4.0M
NIA NIH HHS R01 AG082730
6 · The paper itself

Abstract

Single-cell transcriptomics resolves cellular heterogeneity within individuals, but connecting molecular states to individual-level phenotypes requires frameworks that explicitly bridge these scales. We present scVIP, a generative model that links gene expression, cell-type composition, and phenotypic measurements within a single probabilistic model, which enables accurate phenotype prediction and interpretable trajectory inference. A cell-type-aware multi-instance learning architecture learns donor embeddings that capture progression while localizing phenotype-associated signals to specific cell populations. Applied across four settings, scVIP accurately predicts cortical developmental age (Pearson r = 0.95), characterizes Huntington's disease progression (concordance correlation coefficient = 0.90), integrates two Alzheimer's disease cohorts recovering disease-relevant microglial and astrocytic programs, and distinguishes healthy from ACPA-positive individuals and non-progressors from early RA individuals, identifying inflammatory T cell programs associated with disease. scVIP enables principled analysis of how cellular states collectively shape organism-level phenotypes across development and disease.

Identifiers

PMID42079230
PMCPMC13131499

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.